Szkudelska Katarzyna, Nogowski Leszek, Szkudelski Tomasz
Department of Animal Physiology and Biochemistry, University of Life Sciences in Poznan, 60-637 Wolynska 35, Poznan, Poland.
J Steroid Biochem Mol Biol. 2009 Jan;113(1-2):17-24. doi: 10.1016/j.jsbmb.2008.11.001. Epub 2008 Nov 12.
Resveratrol is a naturally occurring diphenolic compound exerting numerous beneficial effects in the organism. The present study demonstrated its short-term, direct influence on lipogenesis, lipolysis and the antilipolytic action of insulin in freshly isolated rat adipocytes. In fat cells incubated for 90 min with 125 and 250 microM resveratrol (but not with 62.5 microM resveratrol), basal and insulin-induced lipogenesis from glucose was significantly reduced. The antilipogenic effect was accompanied by a significant diminution of CO(2) release and enhanced production of lactate. The inhibition of glucose conversion to lipids found in the presence of resveratrol was not attenuated by activator of protein kinase C. However, acetate conversion to lipids appeared to be insensitive to resveratrol. In adipocytes incubated for 90 min with epinephrine, 10 and 100 microM resveratrol significantly enhanced lipolysis, especially at lower concentrations of the hormone. However, the lipolytic response to dibutyryl-cAMP, a direct activator of protein kinase A, was unchanged. Further studies demonstrated that, in cells stimulated with epinephrine, 1, 10 and 100 microM resveratrol significantly enhanced glycerol release despite the presence of insulin or H-89, an inhibitor of protein kinase A. The influence of resveratrol on epinephrine-induced lipolysis and on the antilipolytic action of insulin was not abated by the blocking of estrogen receptor and was accompanied by a significant (with the exception of 1 microM resveratrol in experiment with insulin) increase in cAMP in adipocytes. It was also revealed that resveratrol did not change the proportion between glycerol and fatty acids released from adipocytes exposed to epinephrine. Results of the present study revealed that resveratrol reduced glucose conversion to lipids in adipocytes, probably due to disturbed mitochondrial metabolism of the sugar. Moreover, resveratrol increased epinephrine-induced lipolysis. This effect was found also in the presence of insulin and resulted from the synergistic action of resveratrol and epinephrine. The obtained results provided evidence that resveratrol affects lipogenesis and lipolysis in adipocytes contributing to reduced lipid accumulation in these cells.
白藜芦醇是一种天然存在的双酚类化合物,在生物体内发挥着多种有益作用。本研究证明了其对新鲜分离的大鼠脂肪细胞中脂肪生成、脂肪分解及胰岛素抗脂解作用的短期直接影响。在用125和250微摩尔白藜芦醇(而非62.5微摩尔白藜芦醇)孵育90分钟的脂肪细胞中,基础及胰岛素诱导的葡萄糖脂肪生成显著减少。抗脂肪生成作用伴随着二氧化碳释放的显著减少及乳酸生成的增加。蛋白激酶C激活剂未减弱白藜芦醇存在时所发现的葡萄糖向脂质转化的抑制作用。然而,乙酸盐向脂质的转化似乎对白藜芦醇不敏感。在用肾上腺素孵育90分钟的脂肪细胞中,10和100微摩尔白藜芦醇显著增强脂肪分解,尤其是在较低激素浓度时。然而,对蛋白激酶A的直接激活剂二丁酰环磷腺苷的脂解反应未改变。进一步研究表明,在用肾上腺素刺激的细胞中,1、10和100微摩尔白藜芦醇尽管存在胰岛素或蛋白激酶A抑制剂H - 89,仍显著增强甘油释放。白藜芦醇对肾上腺素诱导的脂肪分解及胰岛素抗脂解作用的影响未因雌激素受体阻断而减弱,且伴随着脂肪细胞中cAMP显著增加(胰岛素实验中1微摩尔白藜芦醇除外)。还发现白藜芦醇未改变暴露于肾上腺素的脂肪细胞释放的甘油与脂肪酸之间的比例。本研究结果表明,白藜芦醇减少脂肪细胞中葡萄糖向脂质的转化可能是由于糖的线粒体代谢紊乱。此外,白藜芦醇增加肾上腺素诱导的脂肪分解。在存在胰岛素的情况下也发现了这种作用,这是白藜芦醇和肾上腺素协同作用的结果。所得结果证明白藜芦醇影响脂肪细胞中的脂肪生成和脂肪分解,有助于减少这些细胞中的脂质积累。